Quarters are matched automatically on the comparison year: pick once, both periods stay aligned.
| Line item | FY2026 (Q2) | FY2025 (Q2) |
|---|---|---|
| Revenue | $930.8M | $915.2M |
| COGS | $691.2M | $681.2M |
| Gross Profit | $239.6M | $234M |
| R&D | $20.5M | $22.4M |
| SG&A | $0 | $154.2M |
| D&A | $0 | $0 |
| Other OpEx | $161.7M |
QuarterCharts · SEC EDGAR data · DBD · Comparing FY2026 (Q2) vs FY2025 (Q2)
| $1.2M |
| Restructuring Charges | $19.6M | — |
| Other OpEx (derived) | $142.1M | — |
| Operating Income | $57.4M | $56.2M |
| Interest Exp. | $24.1M | $39M |
| Other Non-Op | $0 | $0 |
| Non-Op Income | $3M | $0 |
| Pretax Income | $36.3M | $17.2M |
| Tax | $19.2M | $4.8M |
| Other (Below Tax) | $0 | $0 |
| Other Income (After Tax) | $0 | $0 |
| Equity Method Income | — | $300K |
| Equity Method Income (Loss) | $900K | — |
| Tax Benefit | $0 | $0 |
| Net Income Consolidated | $16.2M | $12.7M |
| Noncontrolling Interest | $700K | $500K |
| Net Income | $15.5M | $12.2M |
